Skip to main content
. 2018 Jan 8;75(3):320–327. doi: 10.1001/jamaneurol.2017.4011

Figure 3. Drug Survival and Reasons for Therapy Discontinuation for Stockholm and Västerbotten Counties.

Figure 3.

Plots depicting the different outcomes for the cohorts in Stockholm and Västerbotten Counties: (A) Kaplan-Meier curve for drug survival, cumulative incidence curves of reasons for therapy discontinuation in Västerbotten (B) and Stockholm Counties (C).